神經血管線圈栓塞補助設備的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，治療，預測(～2033年)

神經血管線圈栓塞輔助裝置在線圈栓塞過程中使用，以幫助將線圈放置在動脈瘤內時將其固定到位。神經血管彈簧圈栓塞輔助裝置包括彈簧圈栓塞輔助支架和彈簧圈栓塞輔助球囊。

神經血管彈簧圈栓塞輔助裝置的使用因國家而異，取決於病例的複雜性、成本和醫生的偏好。球囊的使用略高於支架，但這因國家而異。一些國家選擇更便宜的氣球。由於新技術和成本下降，球囊與支架的使用比例預計每年都會發生變化。

本報告提供全球神經血管線圈栓塞補助設備市場相關調查分析，提供主要企業市場佔有率，主要趨勢，創新的產品與技術，競爭情形等資訊。

市場模式的主要內容如下列。

已上市的神經血管線圈栓塞補助設備與不斷變化的競爭格局

• 主要的產業趨勢的考察
• 神經血管線圈栓塞補助設備市場區隔的年度收益與市場預測(2015年～2033年)
• 台數，平均銷售價格，市場金額相關市場層級的資料

世界，地區，國家層級的市場固有的考察

• 各地區分類的全球趨勢之特定市場定性資訊和國家/地區考慮因素
• 神經血管線圈栓塞補助設備市場SWOT分析
• 神經血管線圈栓塞補助設備市場競爭動態的考察和趨勢

透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Stryker Corp
• MicroVention Inc
• Cerenovus
• Medtronic Plc
• Balt SAS
• 其他

Neurovascular Coiling Assist Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

Neurovascular Coiling Assist Devices are used during coiling procedures to help hold coils in place as they are placed inside the aneurysm. Neurovascular Coiling Assist Devices can be coiling assist stents or coiling assist balloons.

Neurovascular coiling assist device usage varies between countries, depending on the complexity of the case, costs and doctor's preference. There is a slightly higher usage of balloons over stents, however, this varies depending on the country. Some countries may opt to use balloons due to the lower cost of the device. The usage split between balloons and stents are expected to change from year to year depending on new technology and lower costs.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Coiling Assist Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neurovascular Coiling Assist Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neurovascular Coiling Assist Devices market.
• Competitive dynamics insights and trends provided for Neurovascular Coiling Assist Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Stryker Corp, MicroVention Inc, Cerenovus, Medtronic Plc, Balt SAS and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neurovascular Coiling Assist Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Neurovascular Coiling Assist Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Coiling Assist Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neurovascular Coiling Assist Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.